• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于金的抗癌药物的作用模式:结构视角。

The mode of action of anticancer gold-based drugs: a structural perspective.

机构信息

Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino (FI), Italy.

出版信息

Chem Commun (Camb). 2013 Oct 3;49(86):10100-2. doi: 10.1039/c3cc46400h.

DOI:10.1039/c3cc46400h
PMID:24045294
Abstract

The interactions between a few representative gold-based drugs and hen egg white lysozyme were studied by X-ray crystallography. High resolution crystal structures solved for three metallodrug-protein adducts provide valuable insight into the molecular mechanism of these promising metal compounds and the inherent protein metalation processes.

摘要

通过 X 射线晶体学研究了几种代表性的基于金的药物与鸡卵清白溶菌酶之间的相互作用。为三种金属药物 - 蛋白质加合物解析的高分辨率晶体结构提供了有价值的见解,深入了解了这些有前途的金属化合物的分子机制以及固有蛋白质金属化过程。

相似文献

1
The mode of action of anticancer gold-based drugs: a structural perspective.基于金的抗癌药物的作用模式:结构视角。
Chem Commun (Camb). 2013 Oct 3;49(86):10100-2. doi: 10.1039/c3cc46400h.
2
Interaction of anticancer ruthenium compounds with proteins: high-resolution X-ray structures and raman microscopy studies of the adduct between hen egg white lysozyme and AziRu.抗癌钌化合物与蛋白质的相互作用:鸡卵清溶菌酶与 AziRu 加合物的高分辨率 X 射线结构和拉曼显微镜研究。
Inorg Chem. 2013 Apr 15;52(8):4157-9. doi: 10.1021/ic4004142. Epub 2013 Mar 22.
3
Ruthenium metalation of proteins: the X-ray structure of the complex formed between NAMI-A and hen egg white lysozyme.蛋白质的钌金属化:NAMI-A与鸡蛋清溶菌酶形成的复合物的X射线结构。
Dalton Trans. 2014 Apr 28;43(16):6128-31. doi: 10.1039/c3dt53582g.
4
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme.抗癌铂类药物与鸡蛋清溶菌酶加合物的电喷雾电离质谱及X射线衍射研究
Chem Commun (Camb). 2007 Jan 14(2):156-8. doi: 10.1039/b611122j. Epub 2006 Oct 26.
5
Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies.抗癌金属药物与选定蛋白质之间形成的加合物的生物物理特性:来自X射线衍射和质谱研究的新见解。
J Inorg Biochem. 2008 May-Jun;102(5-6):995-1006. doi: 10.1016/j.jinorgbio.2007.12.022. Epub 2008 Jan 8.
6
Re(CO)(3)(H(2)O)(3)(+) binding to lysozyme: structure and reactivity.[Re(CO)(3)(H(2)O)(3)(+)]与溶菌酶的结合:结构与反应性。
Metallomics. 2011 Sep;3(9):909-16. doi: 10.1039/c1mt00065a. Epub 2011 Aug 1.
7
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin.模型蛋白与硫代苹果酸金钠(一种临床应用的金(I)药物)的反应:与金诺芬的比较。
J Inorg Biochem. 2015 Aug;149:102-7. doi: 10.1016/j.jinorgbio.2015.03.013. Epub 2015 Apr 1.
8
Unusual Structural Features in the Adduct of Dirhodium Tetraacetate with Lysozyme.二醋酸合二价铑与溶菌酶加合物的不寻常结构特征。
Int J Mol Sci. 2021 Feb 2;22(3):1496. doi: 10.3390/ijms22031496.
9
Interactions of gold-based drugs with proteins: the structure and stability of the adduct formed in the reaction between lysozyme and the cytotoxic gold(III) compound Auoxo3.金基药物与蛋白质的相互作用:溶菌酶与细胞毒性金(III)化合物Auoxo3反应形成的加合物的结构与稳定性
Dalton Trans. 2014 Dec 14;43(46):17483-8. doi: 10.1039/c4dt02332c.
10
Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compound.金类药物与蛋白质的相互作用:核糖核酸酶 A 与细胞毒性金(III)化合物形成的加合物的晶体结构。
Metallomics. 2014 Feb;6(2):233-6. doi: 10.1039/c3mt00265a.

引用本文的文献

1
Protein Metalation by Medicinal Gold Compounds: Identification of the Main Features of the Metalation Process through ESI MS Experiments.药用金化合物的蛋白质金属化:通过 ESI-MS 实验鉴定金属化过程的主要特征。
Molecules. 2023 Jul 4;28(13):5196. doi: 10.3390/molecules28135196.
2
Graphene as Nanocarrier for Gold(I)-Monocarbene Complexes: Strength and Nature of Physisorption.石墨烯作为金(I)-单卡宾配合物的纳米载体:物理吸附的强度和性质。
Molecules. 2023 May 7;28(9):3941. doi: 10.3390/molecules28093941.
3
Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria.
金药物作为黏菌素助剂用于抗击 MCR-1 产生菌。
J Biol Inorg Chem. 2023 Mar;28(2):225-234. doi: 10.1007/s00775-022-01983-y. Epub 2023 Jan 20.
4
Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey.基于计算化学的金(I)和金(III)抗癌配合物的研究综述
Molecules. 2021 Dec 15;26(24):7600. doi: 10.3390/molecules26247600.
5
In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study.基于计算研究的选定金属化合物的体外抗 SARS-CoV-2 活性及其作用的潜在分子基础。
Biomolecules. 2021 Dec 10;11(12):1858. doi: 10.3390/biom11121858.
6
Targeting Zinc Finger Proteins with Exogenous Metals and Molecules: Lessons learned from Tristetraprolin, a CCCH type Zinc Finger.利用外源金属和分子靶向锌指蛋白:从CCCH型锌指蛋白Tristetraprolin中获得的经验教训
Eur J Inorg Chem. 2021 Oct 7;2021(37):3795-3805. doi: 10.1002/ejic.202100402. Epub 2021 Jul 21.
7
Unusual Structural Features in the Adduct of Dirhodium Tetraacetate with Lysozyme.二醋酸合二价铑与溶菌酶加合物的不寻常结构特征。
Int J Mol Sci. 2021 Feb 2;22(3):1496. doi: 10.3390/ijms22031496.
8
Metabolic Aspects of Palladium(II) Potential Anti-Cancer Drugs.钯(II)潜在抗癌药物的代谢方面
Front Oncol. 2020 Oct 12;10:590970. doi: 10.3389/fonc.2020.590970. eCollection 2020.
9
NMR-Based Metabolomics in Metal-Based Drug Research.基于 NMR 的金属药物研究中的代谢组学。
Molecules. 2019 Jun 15;24(12):2240. doi: 10.3390/molecules24122240.
10
Inhibition Mechanism of Urease by Au(III) Compounds Unveiled by X-ray Diffraction Analysis.通过X射线衍射分析揭示Au(III)化合物对脲酶的抑制机制
ACS Med Chem Lett. 2019 Jan 4;10(4):564-570. doi: 10.1021/acsmedchemlett.8b00585. eCollection 2019 Apr 11.